CN1030037C - Method for preparation of intestine dialysis powder - Google Patents
Method for preparation of intestine dialysis powder Download PDFInfo
- Publication number
- CN1030037C CN1030037C CN 89107685 CN89107685A CN1030037C CN 1030037 C CN1030037 C CN 1030037C CN 89107685 CN89107685 CN 89107685 CN 89107685 A CN89107685 A CN 89107685A CN 1030037 C CN1030037 C CN 1030037C
- Authority
- CN
- China
- Prior art keywords
- dialysis
- preparation
- powder
- present
- dialysis powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a preparation method and application thereof for dialysis powder which is suitable for treating chronic renal failure. The present invention has the technical scheme that the osmotic pressure is improved by hypertonic substance mirabilite which is difficult to absorb in intestinal tracts, the mirabilite is matched and mixed with main ions required by a human body, and the dialysis powder is formed. When in use, the dialysis powder is dissolved in water, and the solution of the dialysis powder is used for dialyzing so that metabolic waste is dialyzed and is discharged out of the human body. Preparation method and application thereof of the present invention have the advantages of simplicity, convenience and good dialysis effects. The clinical practice proves that about 2000 ml of liquid can be brought out by 1000 ml of intestinal dialysis solution. The dialysis cost of the present invention is from 10 times to 20 times lower than the cost of peritoneal dialysis.
Description
The present invention relates to a kind of preparation method of intestinal dialysis powder, this intestinal dialysis powder is applicable to the treatment of chronic renal failure.
The prescription of hemodialysis, peritoneal dialysis, full intestines and stomach dialysis and full intestines and stomach dialysis solution is disclosed in June, 1985 " foreign medical science " magazine department of pediatrics fascicle " the oral dialysis treatment children with chronic renal failure " literary composition.Preceding two kinds of dialysis solution need through autoclaving, the expense costliness, and processing technology and dialysis process complexity and complication are many, and a kind of method dosage in back is big, and is also bigger to the intestines and stomach interference, is difficult to generally use in clinical.
The object of the invention is to overcome above-mentioned shortcoming of the prior art and a kind of method for preparing the intestinal dialysis powder is provided.
The object of the invention can be achieved through the following technical solutions: following each composition is mixed as following weight percent:
Natrii Sulfas 40.00%-88.00%
Glucose 2.15%-19.80%
Sodium chloride 3.66%-28.00%
Calcium chloride 0.21%-2.26%
Magnesium chloride 0.14%-1.37%
Sodium lactate 3.80%-34.20%
During use, get above-mentioned dialysis powder 40-120 gram and be dissolved in 1000 ml waters, close the dialysis of loop intestinal, waste metabolite in blood is dialysed out, excrete with its solution.
Below in conjunction with embodiment, the invention will be further described: the chronic renal failure patient who needs dialysis treatment is executed earlier close loop intestinal tube molding operation and plant the Dialysis tubing operation, treat that postoperative intestine pipe restore funcitons can use intestinal dialysis powder 65 grams of following percentage by weight to dissolve in and carry out the intestinal dialysis in 1000 ml waters:
Natrii Sulfas 78.0%
Glucose 4.0%
Sodium chloride 9.0%
Calcium chloride 0.5%
Magnesium chloride 0.3%
Sodium lactate 7.8%
The osmotic pressure of above-mentioned solution is 750MOSM/L.Be heated to 100 ℃, be cooled to 37 ℃ then.Each conduit of using injects the 150-200 milliliter in intestinal tube, stop and emit after 5-10 minute, and water and metabolite are discharged thereupon.
For suppressing the growth of antibacterial in the intestinal, in above-mentioned intestinal dialysis powder, can add an amount of antibiotics.
The present invention preparation and use easyly, dialysis-effect is good.Clinical practice proves that 1000 milliliters of intestinal dialysis solutions can be taken about 2000 milliliters of liquid out of.The present invention's dialysis than the low 10-20 of peritoneal dialysis cost doubly.
Claims (3)
1, a kind of preparation method for the treatment of chronic renal failure intestinal dialysis powder, this method are that following each composition is mixed, and the percentage by weight of each composition is:
Natrii Sulfas 40.00%-88.00%
Glucose 2.15%-19.80%
Sodium chloride 3.66%-28.00%
Calcium chloride 0.21%-2.26%
Magnesium chloride 0.14%-1.37%
Sodium lactate 3.80%-34.20%
2,, it is characterized in that said percentage by weight is according to the preparation method of the described intestinal dialysis powder of claim 1:
Natrii Sulfas 78.0%
Glucose 4.0%
Sodium chloride 9.0%
Calcium chloride 0.5%
Magnesium chloride 0.3%
Sodium lactate 7.8%
3, according to the preparation method of claim 1 or 2 described intestinal dialysis powders, it is characterized in that also containing in the said composition an amount of antibiotics.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 89107685 CN1030037C (en) | 1989-09-26 | 1989-09-26 | Method for preparation of intestine dialysis powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 89107685 CN1030037C (en) | 1989-09-26 | 1989-09-26 | Method for preparation of intestine dialysis powder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1041278A CN1041278A (en) | 1990-04-18 |
| CN1030037C true CN1030037C (en) | 1995-10-18 |
Family
ID=4857302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 89107685 Expired - Fee Related CN1030037C (en) | 1989-09-26 | 1989-09-26 | Method for preparation of intestine dialysis powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1030037C (en) |
-
1989
- 1989-09-26 CN CN 89107685 patent/CN1030037C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1041278A (en) | 1990-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5906978A (en) | Method for iron delivery to a patient by transfer from dialysate | |
| CN1163236C (en) | Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis | |
| US7053059B2 (en) | Dialysis solutions with reduced levels of glucose degradation products | |
| Nolph et al. | Theoretical and practical implications of continuous ambulatory peritoneal dialysis | |
| US20040121982A1 (en) | Biocompatible dialysis fluids containing icodextrins | |
| EP1753437A1 (en) | Bicarbonate-based peritoneal dialysis solutions | |
| WO1983000087A1 (en) | Peritoneal dialysis solution containing carbohydrate polymers | |
| Steiner | Continuous equilibration peritoneal dialysis in acute renal failure | |
| CN1030037C (en) | Method for preparation of intestine dialysis powder | |
| US20130197428A1 (en) | Peritoneal Dialysis Method | |
| US20090016984A1 (en) | Drug for Hyperphospheremia and Its Preparative Method | |
| JP3589701B2 (en) | Peritoneal dialysis solution containing trehalose | |
| CN1739531A (en) | Ferric saccharate injection for treating iron-deficiency anemia and its prepn process | |
| JPH11510499A (en) | Calcium-containing composition for intestinal phosphate binding and method of making same | |
| Ing et al. | Bicarbonate-buffered peritoneal dialysis | |
| Paton et al. | Tobramycin disposition in patients on continuous ambulatory peritoneal dialysis | |
| Marichal et al. | Peritonitis in continuous ambulatory peritoneal dialysis: a role for the dialysate? | |
| CA1257203A (en) | Dialysis with monophosphoryl lipid a | |
| JPH01151462A (en) | Fluid for peritoneal perfusion | |
| Ing et al. | Peritoneal dialysis using conventional, lactate-containing solution sterilized by ultrafiltration | |
| JP4087929B2 (en) | Composition for treating chronic renal failure in cats and method for treating the same | |
| JP2722131B2 (en) | Peritoneal dialysate | |
| Villarroel | Future of intracorporeal dialysis | |
| CN1089153A (en) | Dialysate for intestinal cavity and preparation thereof | |
| CN1027959C (en) | Zn-Ca oral liquid and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |